Skip to content
Original
mp.weixin.qq.com·· 7 hours agoPickScore64

MetaTen Pharma and Eli Lilly Strike AI Drug Delivery Deal Worth Up to 1.1 Billion Dollars

In brief

MetaTen Pharma (7666.HK) announced a strategic collaboration with Eli Lilly carrying an upfront payment of over ten million US dollars and a total value of up to 1.1 billion US dollars, focused on AI-driven drug delivery solutions. The partners will jointly develop novel lipid nanoparticle (LNP) delivery systems and explore tissue-specific delivery technology adaptable to multiple therapeutic modalities, with Lilly mobilizing resources across drug discovery, clinical development and commercialization.

Why it matters

The deal discloses both the upfront payment and up to 1.1 billion dollar total value, plus Lilly's discovery-to-commercialization resources, aiding assessment of AI delivery projects.

Source: mp.weixin.qq.com · mp.weixin.qq.com

#Deals & financing#AI in drug discovery#Eli Lilly
CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.